Rothschild Investment LLC Annexon, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 420 shares of ANNX stock, worth $798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
420
Previous 75
460.0%
Holding current value
$798
Previous $385,000
110.65%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
154Shares Held
98MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$14.1 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$13.3 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$12.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$12 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$10.7 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $90.5M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...